login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANAVEX LIFE SCIENCES CORP (AVXL) Stock News
USA
-
Nasdaq
- NASDAQ:AVXL -
US0327973006
-
Common Stock
3.26
USD
+0.09 (+2.84%)
Last: 11/21/2025, 8:12:59 PM
3.25
USD
-0.01 (-0.31%)
After Hours:
11/21/2025, 8:12:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AVXL Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Chartmill
- Mentions:
CDTX
SRRK
KXIN
PGEN
...
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session.
9 days ago - By: Chartmill
- Mentions:
CDTX
BCAB
NVVE
NVNO
...
Which stocks are moving on Friday?
4 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
4 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
4 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
5 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
6 days ago - By: Stocktwits
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'
9 days ago - By: Benzinga
- Mentions:
PTN
ZYXI
CDTX
CMND
...
12 Health Care Stocks Moving In Friday's Intraday Session
9 days ago - By: Chartmill
- Mentions:
CDTX
AVDL
SRRK
KXIN
...
Let's uncover which stocks are experiencing notable gaps during today's session.
9 days ago - By: Chartmill
- Mentions:
CDTX
NVVE
NVNO
GWH
...
Discover the top movers in Friday's pre-market session.
9 days ago - By: Benzinga
- Mentions:
VSTM
TSSI
SEI
RCAT
...
Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session
9 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease
9 days ago - By: Stocktwits
AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug
9 days ago - By: Stocktwits
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug?
12 days ago - By: Stocktwits
- Mentions:
IWMW
EAOR
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee
25 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
a month ago - By: Stocktwits
Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
2 months ago - By: Stocktwits
- Mentions:
EAOR
ITOT
Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial
2 months ago - By: Stocktwits
- Mentions:
EAOR
VTWG
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial
3 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
3 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine
3 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
Please enable JavaScript to continue using this application.